Dr. Reddy’s Laboratories Ltd. and Senores Pharmaceuticals, Inc. today announced the launch of Ketorolac Tromethamine Tablets USP, 10 mg, a therapeutic generic equivalent of the reference listed drug Toradol Tablets, 10 mg in the U.S. market approved by the U.S. Food and Drug Administration (USFDA).
The Toradol Tablets, 10 mg brand and generic had U.S. sales of approximately $16.8M MAT for the most recent twelve months ending in March 2022 according to IQVIA*.Dr. Reddy’s Ketorolac Tromethamine Tablets USP, 10 mg, are available in bottle count sizes of 100.